Petasites hybridus root (butterbur) is an effective preventive treatment for migraine

Neurology

Volumn 63, Issue 12, 2004, Pages 2240-2244

  Lipton, R B ^a   Gobel H ^d   Einhaupl K M ^e   Wilks, K ^f   Mauskop, A ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b New York Headache Center   (United States)

^c AdvancePCS Company   (United States)

^d UNIVERSITY OF KIEL   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f Rousso Bldg ^*

Author keywords

[No Author keywords available]

Indexed keywords

PETASITES HYBRIDUS EXTRACT; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EAR DISEASE; EYE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; INFECTION; INFESTATION; INNER EAR DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MEDICAL SOCIETY; MIGRAINE; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PAIN ASSESSMENT; PETASITES; PETASITES HYBRIDUS; PLANT; PLANT ROOT; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SUBCUTANEOUS FAT DISORDER; THORAX DISEASE;

PETASITES HYBRIDUS;

EID: 11144320704     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000147290.68260.11     Document Type: Article

References (26)

1. Lipton RB, Scher AI, Steiner TJ, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003;60:441-448.
2. Silberstein SD, Lipton RB, Dalessio DJ, ed. Wolff's headache and other head pain. 7th ed. Oxford, UK: Oxford University Press, 2001.
3. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo controlled trial of feverfew in migraine prevention. Lancet 1988;2:189-192.
4. Johnson ES, Kadam NP, Hylands DM, Huylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J 1985;291:569-573.
5. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-263.
6. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50:466-470.
7. Grossman M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 2000;38:430-435.
8. Ziolo G, Samochewiec L. Study on clinical properties and mechanism of action of Petasites in bronchial asthma and chronic obstructive bronchitis. Pharm Acta Helv 1998;72:359-380.
9. Barsom S. Behandlung von Koliken und Spasmen in der Urologie mit einem pflanzlichen Spasmolytikum. Erfahrungsheilkunde 1986;35:1-11.
10. Gruia FS. Pflanzliche Analgetika-Therapie bei WS-Syndrom. Biol Med 1987;3:454.
11. Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004;51:89-97.
12. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96.
13. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762.
14. Gray RN, Goslin RE, McCrory DC, et al. Drug treatment for the prevention of migraine headache. Technical review 2.3, February 1999. Prepared for the Agency for Health Care Policy and Research under contract number 29009402025. Available from the National Technical Information Service; NTIS accession no. 127953.
15. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281-286.
16. Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41:119-128.
17. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001;41:968-975.
18. Thomet OA, Wiesmann UN, Blaser K, Simon HU. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. Clin Exp Allergy 2001;31:1310-1320.
19. Brune K, Bickel D, Peskar BA. Gastro-protective effects by extracts of Petasites hybridus: the role of inhibition of peptido-leukotriene synthesis. Plants Med 1993;59:494-496.
20. Scheidegger C, Dahinden C, Wiesmann U. Effects of extracts of individual components from Petasites on prostaglandin synthesis in cultured skin fibroblasts and on leucotriene synthesis in isolated human peripheral leucocytes. Pharm Acta Helv 1998;72:359-380.
21. Thomet OA, Wiesmann UN, Schapowal A, Bizer C, Simon H. Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus. Biochem Pharmacol 2001;61:1041-1047.
22. Sheftell F, Rapoport A, Weeks R, Walker B, Gammerman I, Baskin S. Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Headache 2000;40:158-163.
23. Pearlman EM, Fisher S. Preventive treatment for childhood and adolescent headache: role of once-daily montelukast sodium. Cephalalgia 2001;21:461.
24. Ko W, Lei C, Lin Y, Chen C. Mechanisms of relaxant action of S-petasine and S-Isopetasin, sesquiterpenes of Petasites formosanus, in isolated guinea pig trachea. Planta Med 2001;67:224-229.
25. Wang G-J, Shum AY-C, Lin Y-L, et al. Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasine, a hypotensive sesquiterpene from Petasites formosanus. J Pharmacol Exp Ther 2001;297:240-246.
26. Danesch U, Rittinghausen R. Safety of a patented special butterbur root extract for migraine prevention. Headache 2003;43:76-78.